Abstract |
The efficacy of parvaquone (Clexon) and buparvaquone (Butalex) in treating experimentally induced feline cytauxzoonosis was explored. Domestic cats were inoculated subcutaneously with blood from a cat infected with Cytauxzoon felis and treated daily with either 20 or 30 mg kg-1 parvaquone, or 5 or 10 mg kg-1 buparvaquone, beginning on either the first day parasites were detected in peripheral blood, or 2 days after the onset of parasitemia. Fifteen cats were treated and all but one died due to the infection. Unexpectedly, one of two non-treated, infected control cats survived. Although parvaquone and buparvaquone are the treatments of choice for a related hemoprotozoan parasite causing theileriosis in African cattle, wer concluded that at the dosages and regimes tested, these drugs are not effective treatments for feline cytauxzoonosis. Blood from the two surviving cats was inoculated into naive cats and in these animals clinical disease or death were not observed. The latter two naive recipient cats were then inoculated with a lethal dose of viable, frozen C. felis and both died, thereby indicating that blood from surviving cats did not induce an infectious state that resulted in immunity. The two cats that survived the acute infection were subsequently challenged with a lethal inoculum of C. felis; they showed no clinical signs of cytauxzoonosis and were obviously immune to reinfection.
|
Authors | S L Motzel, J E Wagner |
Journal | Veterinary parasitology
(Vet Parasitol)
Vol. 35
Issue 1-2
Pg. 131-8
(Feb 1990)
ISSN: 0304-4017 [Print] Netherlands |
PMID | 2111598
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antiprotozoal Agents
- Naphthoquinones
- buparvaquone
- parvaquone
|
Topics |
- Animals
- Antiprotozoal Agents
(therapeutic use)
- Apicomplexa
- Cat Diseases
(drug therapy)
- Cats
- Female
- Male
- Naphthoquinones
(therapeutic use)
- Protozoan Infections
(drug therapy)
- Protozoan Infections, Animal
|